60 related articles for article (PubMed ID: 15650365)
1. Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection.
Jimenez C; Moran SA; Sereti I; Wynne S; Yen PM; Falloon J; Davey RT; Sarlis NJ
Thyroid; 2004 Dec; 14(12):1097-102. PubMed ID: 15650365
[TBL] [Abstract][Full Text] [Related]
2. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients.
Jubault V; Penfornis A; Schillo F; Hoen B; Izembart M; Timsit J; Kazatchkine MD; Gilquin J; Viard JP
J Clin Endocrinol Metab; 2000 Nov; 85(11):4254-7. PubMed ID: 11095463
[TBL] [Abstract][Full Text] [Related]
3. Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review.
Knysz B; Bolanowski M; Klimczak M; Gladysz A; Zwolinska K
Viral Immunol; 2006; 19(1):102-7. PubMed ID: 16553555
[TBL] [Abstract][Full Text] [Related]
4. Serum cytokines in thyrotoxicosis.
Siddiqi A; Monson JP; Wood DF; Besser GM; Burrin JM
J Clin Endocrinol Metab; 1999 Feb; 84(2):435-9. PubMed ID: 10022397
[TBL] [Abstract][Full Text] [Related]
5. Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
Wang F; Chen L; Shen Q; Liu T; Jiang L; Gu X; Chen L; Sun J; Liu C
Immunol Lett; 2015 May; 165(1):47-51. PubMed ID: 25839128
[TBL] [Abstract][Full Text] [Related]
6. Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease.
Marazuela M; Vargas JA; Alvarez-Mon M; Albarrán F; Lucas T; Durántez A
Eur J Endocrinol; 1995 Feb; 132(2):175-80. PubMed ID: 7858736
[TBL] [Abstract][Full Text] [Related]
7. Possible induction of Graves' disease and painless thyroiditis by gonadotropin-releasing hormone analogues.
Amino N; Hidaka Y; Takano T; Tatsumi KI; Izumi Y; Nakata Y
Thyroid; 2003 Aug; 13(8):815-8. PubMed ID: 14558924
[TBL] [Abstract][Full Text] [Related]
8. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease.
Chen F; Day SL; Metcalfe RA; Sethi G; Kapembwa MS; Brook MG; Churchill D; de Ruiter A; Robinson S; Lacey CJ; Weetman AP
Medicine (Baltimore); 2005 Mar; 84(2):98-106. PubMed ID: 15758839
[TBL] [Abstract][Full Text] [Related]
10. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
Bossowski A; Moniuszko M; Dąbrowska M; Sawicka B; Rusak M; Jeznach M; Wójtowicz J; Bodzenta-Lukaszyk A; Bossowska A
Autoimmunity; 2013 May; 46(3):222-30. PubMed ID: 23249428
[TBL] [Abstract][Full Text] [Related]
11. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
Bossowski A; Stasiak-Barmuta A; Urban M
Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
[TBL] [Abstract][Full Text] [Related]
12. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease.
Mao C; Wang S; Xiao Y; Xu J; Jiang Q; Jin M; Jiang X; Guo H; Ning G; Zhang Y
J Immunol; 2011 Apr; 186(8):4734-43. PubMed ID: 21398613
[TBL] [Abstract][Full Text] [Related]
13. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
[TBL] [Abstract][Full Text] [Related]
14. The clinical role of serum concentrations of selected cytokines: IL-1β, TNF-α and IL-6 in diagnosis of autoimmune thyroid disease (AITD) in children.
Mikos H; Mikos M; Rabska-Pietrzak B; Niedziela M
Autoimmunity; 2014 Nov; 47(7):466-72. PubMed ID: 24801540
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4(+) T-cell recovery.
Sheikh V; Dersimonian R; Richterman AG; Porter BO; Natarajan V; Burbelo PD; Rupert A; Santich BH; Kardava L; Mican JM; Moir S; Sereti I
AIDS; 2014 Jan; 28(1):31-9. PubMed ID: 23939238
[TBL] [Abstract][Full Text] [Related]
16. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
[TBL] [Abstract][Full Text] [Related]
17. Serum cytokines levels in Graves' disease.
Al-Humaidi MA
Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
Saitoh O; Nagayama Y
Endocrinology; 2006 May; 147(5):2417-22. PubMed ID: 16439459
[TBL] [Abstract][Full Text] [Related]
19. CD5+ B cells in Graves' disease: correlation with disease activity.
Corrales JJ; Orfao A; López A; Mories MT; Miralles JM; Ciudad J
Horm Metab Res; 1996 Jun; 28(6):280-5. PubMed ID: 8811329
[TBL] [Abstract][Full Text] [Related]
20. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
